BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Phenobarbital
,
rs6983267
,
BRAF
,
G-protein-coupled receptor binding
,
Embryo
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
oxymorphone
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
OPRM1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
Mu opioid receptor
morphine receptor activity
negative regulation of Wnt protein secretion
Opioid receptor
negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Effect of amantadine on oxymorphone-induced thermal antinociception in cats.
Simultaneous determination of oxymorphone and its active metabolite 6-OH-oxymorphone in human plasma…
The effects of ethanol on the bioavailability of oxymorphone extended-release tablets and oxymorphon…
An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in…
Observations on the urine metabolic ratio of oxymorphone to oxycodone in pain patients.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain
Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain
Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ